| Pieris Pharmaceuticals, Inc. PIRS | $3.78B | 1561.07 | 20.61M | 0% | +$0 | 27.72 | |
| Cidara Therapeutics, Inc. CDTX | $6.31B | 150.41 | 6.86M | 0% | +$0 | 46.34 | |
MoonLake Immunotherapeutics MLTX | $1.09B | 34.06 | 21.75M | 0% | +$0 | 8.02 | |
| XOMA Corporation XOMA | $87.39M | 31.22 | 3.63M | 0% | +$0 | 0.64 | |
| Repare Therapeutics Inc. RPTX | $48.67M | 24.35 | 10.33M | 0% | +$0 | 0.36 | |
GH Research PLC GHRS | $110.87M | 19.99 | 10.4M | 0% | +$0 | 0.81 | |
| ESSA Pharma Inc. EPIX | $74.28M | 19.72 | 8.75M | 0% | +$0 | 0.55 | |
| Allakos Inc. ALLK | $20.86M | 18.69 | 16.55M | +93.54% | +$10.08M | 0.15 | |
| Olema Pharmaceuticals, Inc. OLMA | $103.42M | 16.33 | 9.14M | 0% | +$0 | 0.76 | |
| GlycoMimetics, Inc. GLYC | $28.63M | 14.81 | 9.54M | 0% | +$0 | 0.21 | |
AC Immune SA ACIU | $43.13M | 14.69 | 14.57M | 0% | +$0 | 0.32 | |
| Eledon Pharmaceuticals, Inc. ELDN | $8.91M | 11.24 | 4.33M | 0% | +$0 | 0.07 | |
Third Harmonic Bio, Inc. THRD | $41.21M | 10.66 | 4.37M | 0% | +$0 | 0.3 | |
| Immunic, Inc. IMUX | $11.75M | 9.88 | 8.9M | New | +$11.75M | 0.09 | |
| Ikena Oncology, Inc. IKNA | $6.77M | 9.88 | 4.77M | 0% | +$0 | 0.05 | |
| Mirum Pharmaceuticals, Inc. MIRM | $109.78M | 9.27 | 4.37M | 0% | +$0 | 0.81 | |
| Viracta Therapeutics, Inc. VIRX | $3.69M | 9.2 | 3.61M | 0% | +$0 | 0.03 | |
| Tyra Biosciences, Inc. TYRA | $76.44M | 8.87 | 4.66M | +70.14% | +$31.51M | 0.56 | |
| CytomX Therapeutics, Inc. CTMX | $14.38M | 8.47 | 6.6M | 0% | +$0 | 0.11 | |
| Kymera Therapeutics, Inc. KYMR | $207.5M | 8.41 | 5.16M | 0% | +$0 | 1.52 | |
| Zymeworks Inc. ZYME | $61.75M | 8.3 | 5.87M | 0% | +$0 | 0.45 | |
| Forte Biosciences, Inc. FBRX | $2.09M | 8.18 | 2.98M | 0% | +$0 | 0.02 | |
| 4D Molecular Therapeutics, Inc. FDMT | $124.97M | 7.59 | 3.92M | -2.12% | -$2.71M | 0.92 | |
| Annexon, Inc. ANNX | $50.19M | 7.58 | 7M | 0% | +$0 | 0.37 | |
VistaGen Therapeutics, Inc. VTGN | $10.56M | 7.4 | 2M | 0% | +$0 | 0.08 | |
| Verastem, Inc. VSTM | $19.89M | 6.65 | 1.69M | 0% | +$0 | 0.15 | |
| Protagonist Therapeutics, Inc. PTGX | $108.66M | 6.4 | 3.76M | -34.62% | -$57.54M | 0.8 | |
| Kura Oncology, Inc. KURA | $102.09M | 6.28 | 4.79M | -35.09% | -$55.18M | 0.75 | |
TScan Therapeutics, Inc. TCRX | $23.74M | 5.66 | 2.99M | 0% | +$0 | 0.17 | |
| Janux Therapeutics, Inc. JANX | $109.93M | 5.63 | 2.92M | -36.25% | -$62.5M | 0.81 | |
| Cullinan Oncology, Inc. CGEM | $54.47M | 5.55 | 3.2M | 0% | +$0 | 0.4 | |
| Ovid Therapeutics Inc. OVID | $11.75M | 5.43 | 3.85M | -43.75% | -$9.14M | 0.09 | |
| Kronos Bio, Inc. KRON | $3.78M | 4.83 | 2.91M | 0% | +$0 | 0.03 | |
| Vigil Neuroscience, Inc. VIGL | $6.18M | 4.83 | 1.81M | 0% | +$0 | 0.05 | |
| Delcath Systems, Inc. DCTH | $5.73M | 4.33 | 1.2M | +23.14% | +$1.08M | 0.04 | |
| Elevation Oncology, Inc. ELEV | $11.86M | 4.23 | 2.31M | 0% | +$0 | 0.09 | |
AN2 Therapeutics, Inc. ANTX | $4.03M | 4.16 | 1.24M | -20.75% | -$1.05M | 0.03 | |
| 89bio, Inc. ETNB | $47.11M | 4.11 | 4.05M | 0% | +$0 | 0.35 | |
| Revolution Medicines, Inc. RVMD | $192.77M | 3.63 | 5.98M | 0% | +$0 | 1.42 | |
Galapagos NV GLPG | $60.01M | 2.83 | 1.86M | -2.68% | -$1.65M | 0.44 | |
CG Oncology, Inc. Common stock CGON | $82.72M | 2.83 | 1.88M | New | +$82.72M | 0.61 | |
Calliditas Therapeutics AB (publ) CALT | $16.24M | 2.52 | 750,000 | 0% | +$0 | 0.12 | |
| Syndax Pharmaceuticals, Inc. SNDX | $44.63M | 2.21 | 1.88M | 0% | +$0 | 0.33 | |
| Merus N.V. MRUS | $52.79M | 2 | 1.17M | -57.41% | -$71.16M | 0.39 | |
| Structure Therapeutics Inc. GPCR | $34.84M | 1.74 | 812,988 | 0% | +$0 | 0.26 | |
| Ionis Pharmaceuticals, Inc. IONS | $105.28M | 1.66 | 2.43M | 0% | +$0 | 0.77 | |
| IDEAYA Biosciences, Inc. IDYA | $51M | 1.54 | 1.16M | -32.78% | -$24.87M | 0.37 | |
| Verve Therapeutics, Inc. VERV | $8.63M | 0.77 | 650,000 | 0% | +$0 | 0.06 | |
| Lexicon Pharmaceuticals, Inc. LXRX | $4.05M | 0.47 | 1.69M | -93.1% | -$54.6M | 0.03 | |
| Roivant Sciences Ltd. ROIV | $28.9M | 0.34 | 2.74M | 0% | +$0 | 0.21 |